Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways

Oncogene volume 19, pages 992–1001 (2000)Cite this article

Abstract

The study of the mouse mammary tumor virus (MMTV) has provided important insights into the mechanisms of gene transcription regulation by steroid hormones, the mode of action of heritable super antigens and the progressive nature of neoplastic transformation in the mammary gland. Here we describe the current situation with respect to the latter aspect of MMTV biology and the prospects for further advance in our understanding of breast cancer in humans that may be expected from a continued study of MMTV-induced mammary neoplasia. MMTV is a heritable somatic mutagen whose target range is limited. Commonly, the tumorigenic capacity of MMTV is restricted to mammary gland, whereas infection is found in a variety of cell types. In order to replicate, proviral DNA must be inserted into the cell DNA and cell division is required to fix the mutation. Yet only in the mammary epithelium does this lead to neoplastic transformation. This suggests a unique relationship between MMTV and mammary epithelium. In evaluating this relationship, we and others have discovered genes and potential gene pathways that are pertinent in mammary differentiation and neoplasia. In addition, the clonal nature of these progressive events from normal to malignant phenotype has become increasingly clear. The weight of these observations compel us to conclude that mammary neoplasms arise from multipotent mammary epithelial cells through a process of acquired mutations that are reflected in the increasingly malignant nature of the population of progeny produced by these damaged stem cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Andervont HB. . 1952 Ann. N.Y. Acad. Sci. 54: 1004–1011.

  • Andervont HB and Dunn TB. . 1962 J. Natl. Cancer Inst. 28: 1153–1163.

  • Artavanis-Tsakonas S, Matsuno K and Fortini ME. . 1995 Science 268: 225–232.

  • Asano K, Merrick WC and Hershey JW. . 1997 J. Biol. Chem. 272: 23477–23480.

  • Axelrod JD, Matsuno K, Artavanis-Tsakonas S and Perrimon N. . 1996 Science 271: 1826–1832.

  • Basillico C and Moscatelli D. . 1992 Adv. Cancer Res. 59: 115–164.

  • Bieche I and Lidereau R. . 1995 Genes Chromosom. Cancer 14: 227–251.

  • Bittner JJ. . 1936 Science 84: 162.

  • Callahan R. . 1996 Breast Cancer Res. Treat. 39: 33–34.

  • Callahan R, Drohan W, Gallahan D, D'Hoostelaere L and Potter M. . 1982 Proc. Natl. Acad. Sci. USA 79: 4113–4117.

  • Callahan R, Gallahan D, D'Hoostelaere LA and Potter M. . 1986 Cur. Topics Microbiol. Immunol. 127: 362–370.

  • Cardiff RD, Morris DW and Young LJT. . 1983 J. Natl. Cancer Inst. 71: 1011–1019.

  • Chen YC, Fischer WH and Gill GN. . 1997 J. Biol. Chem. 272: 14110–14114.

  • Cohen JC, Majors JE and Varmus HE. . 1979a J. Virol. 32: 483–496.

  • Cohen JC, Shank PR, Morris VL, Cardiff R and Varmus HE. . 1979b Cell 16: 333–345.

  • Daniel C, DeOme K, Young L, Blair P and Faulkin L. . 1968 Proc. Natl. Acad. Sci. USA 61: 53–60.

  • Daniel CW and Young LJT. . 1971a Exp. Cell Res. 65: 1971.

  • Daniel CW, Young LJ, Medina D and DeOme KB. . 1971b Exp. Gerontol. 6: 95–101.

  • Delli Bovi P, Curatola A, Kern F, Greco A, Ittmann M and Basilico C. . 1987 Cell 50: 729–737.

  • Deng G, Lu Y, Zlotnikov G, Thor AD and Smith HS. . 1996 Science 274: 2057–2059.

  • DeOme KB, Bern HA and Blair PB. . 1959 J. Natl. Cancer Inst. 78: 751–757.

  • DeOme KB, Miyamoto MJ, Osborn RC, Guzman RC and Lum K. . 1978a Cancer Res. 38: 2103–2111.

  • DeOme KB, Miyamoto MJ, Osborn RC, Guzman RC and Lum K. . 1978b Cancer Res. 38: 4050–4053.

  • Dickson C and Peters G. . 1987 Nature 326: 833.

  • Dickson C, Smith R, Brookes S and Peters G. . 1984 Cell 37: 529–536.

  • Diella F, Levi G and Callahan R. . 1997 DNA Cell Biol. 16: 839–847.

  • Dierick H and Bejsovec A. . 1999 Curr. Top. Dev. Biol. 43: 153–190.

  • Dievart A, Beaulieu N and Jolicoeur P. . 1999 Oncogene In press.

  • Escot C, Hogg E and Callahan R. . 1986 J. Virol. 58: 619–625.

  • Fearon ER, Hamilton SR and Vogelstein B. . 1987 Science 238: 193–197.

  • Felluga B, Claude A and Mrena E. . 1969 J. Natl. Cancer Inst. 43: 319–333.

  • Foulds L. . 1956 J. Natl. Cancer Inst. 17: 713–753.

  • Gallahan D and Callahan R. . 1987a J. Virol. 61: 66–74.

  • Gallahan D and Callahan R. . 1997 Oncogene 14: 1883–1890.

  • Gallahan D, Kozak C and Callahan R. . 1987b J. Virol. 61: 218–220.

  • Gavin BJ, McMahon JA and McMahon AP. . 1990 Genes Dev. 4: 2319–2332.

  • Goldfarb M. . 1990 Cell Growth Diff. 1: 439–445.

  • Golovkina TV, Dzuris J, van den Hoogen B, Jaffe AB, Wright PC, Cofer SM and Ross SR. . 1998 J. Virol. 72: 3066–3071.

  • Held W, Acha-Orbea H, MacDonald RH and Waanders GA. . 1994 Immunol. Today 15: 184–190.

  • Hilgers J and Sluyser M. (eds). . 1981 Mammary Tumors in the Mouse Elsevier/North Holland Bimedical Press: Amsterdam.

    Google Scholar 

  • Hilkens J, van der Zeijst B, Buijs F, Kroezen V, Bleumink N and Hilgers J. . 1983 J. Virol. 45: 140–147.

  • Huguet EL, McMahon JA, McMahon AP, Bicknell R and Harris AL. . 1994 Cancer Res 54: 2615–2621.

  • Imai S, Morimoto J, Tsubura Y, Iwai Y, Okumoto M, Takamori Y, Tsubura A and Hilgers J. . 1983 Eur. J. Cancer Clin. Oncol. 19: 1011–1019.

  • Imai S, Okumoto M, Iwai M, Haga S, Mori N, Miyashita N, Moriwaki K, Hilgers J and Sarkar NH. . 1994 J. Virol. 68: 3437–3442.

  • Jakobovits A, Shackelford GM, Varmus HE and Martin GR. . 1986 Proc. Natl. Acad. Sci. USA 83: 7806–7810.

  • Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino GT and Callahan R. . 1992 Genes Dev. 6: 345–355.

  • Klingensmith J and Nusse R. . 1994 Dev. Biol. 166: 396–414.

  • Kordon EC and Smith GH. . 1998 Development 125: 1921–1930.

  • Kordon EC, Smith GH, Callahan R and Gallahan D. . 1995 J. Virol. 69: 8066–8069.

  • Kwan H, Pecenka V, Tsukamoto A, Parslow TG, Guzman R, Lin TP, Muller WJ, Lee FS, Leder P and Varmus HE. . 1992 Mol. Cell. Biol. 12: 147–154.

  • Lee AE. . 1968 Br. J. Cancer 22: 77–82.

  • Lee FS, Lane TF, Kuo A, Shackleford GM and Leder P. . 1995 Proc. Natl. Acad. Sci. USA 92: 2268–2272.

  • Lieber TC, Kidd S, Alcamo E, Corbin V and Young MW. . 1993 Genes Dev. 7: 1949–1965.

  • MacArthur CA, Shankar DB and Shackleford GM. . 1995 J. Virol. 69: 2501–2507.

  • Marchetti A, Buttitta F, Miyazaki S, Gallahan D, Smith GH and Callahan R. . 1995 J. Virol. 69: 1932–1938.

  • Marchetti A, Robbins J, Campbell G, Buttitta F, Squartini F, Bistocchi M and Callahan R. . 1991 J. Virol. 65: 4550–4554.

  • Medina D. . 1973 Methods Cancer Res. 7: 3–53.

  • Medina D and Smith GH. . 1990 Protoplasms 159: 77–84.

  • Michalides R, van Nie R, Nusse R, Hynes NE and Groner B. . 1981 Cell 23: 165–173.

  • Michalides R, Verstraeten R, Shen FW and Hilgers J. . 1985 Virology 142: 278–290.

  • Miyazaki S, Rasmussen S, Imatani A, Diella F, Sullivan DT and Callahan R. . 1999 Gene 233: 241–247.

  • Morse HC (ed.). . 1978 Origins of Inbred Mice. Academic Press: New York.

    Google Scholar 

  • Muhlbock O. . 1950 J. Natl. Cancer Inst. 10: 861–864.

  • Muller WJ, Lee FS, Dickson C and Peters G. . 1990 EMBO J. 9: 907–913.

  • Muskavitch MAT. . 1994 Dev. Biol. 166: 415–430.

  • Nicoll CS and Tucker HA. . 1965 Life Sci. 4: 993–1001.

  • Nusse R. . 1997 Cell 89: 321–323.

  • Nusse R and Varmus HE. . 1982 Cell 31: 99–109.

  • Nusse R and Varmus HE. . 1992 Cell 69: 1073–1087.

  • Peters G. . 1990 Cell Growth Diff. 1: 503–510.

  • Peters G, Brookes S, Smith R, Placzek M and Dickson C. . 1989 Proc. Natl. Acad. Sci. USA 86: 5678–5682.

  • Qin W, Golovkina TV, Peng T, Nepomnaschy I, Buggiano V, Piazzon I and Ross SR. . 1999 J. Virol. 73: 368–376.

  • Rebay I, Fleming RJ, Fehon RG, Cherbas L and Artavanis-Tsakonas S. . 1991 Cell 67: 687–699.

  • Ringold GM, Shank PR, Varmus HE, Ring J and Yamamoto KR. . 1979 Proc. Natl. Acad. Sci. USA 76: 665–669.

  • Robbins J, Blondel BJ, Gallahan D and Callahan R. . 1992 J. Virol. 66: 2594–2599.

  • Roelink H, Wagenaar E, Silva SLD and Nusse R. . 1990 Proc. Natl. Acad. Sci. USA 87: 4519–4523.

  • Roelink H, Wang J, Black DM, Solomon E and Nusse R. . 1993 Genomics 17: 790–792.

  • Rongey RW, Hlavackova A, Lara S, Estes J and Gardner MB. . 1973 J. Natl. Cancer Inst. 50: 1581–1589.

  • Rosenberg CL, Larson PS, Romo JD, De Las Morenas A and Faller DV. . 1997 Hum. Pathol. 28: 214–219.

  • Ross SR. . 1998 Immunol. Res. 17: 209–216.

  • Roubinian JR and Blair PB. . 1980 J. Natl. Cancer Inst. 65: 795–800.

  • Sarkar NH, Haga S, Lehner AF, Zhao W, Imai S and Moriwaki K. . 1994 Virology 203: 52–62.

  • Schlom J, Horan Hand P, Teramoto Y, Callahan R, Todaro GJ and Schidlovsky G. . 1978 J. Natl. Cancer Inst. 61: 66–74.

  • Schwartz M, Smth G and Medina D. . 1992 Int. J. Cancer 51: 805–811.

  • Sell S and Pierce GB. . 1994 Lab. Invest. 70: 6–22.

  • Shackleford GM, MacArthur CA, Kwan HC and Varmus H. . 1993 Proc. Natl. Acad. Sci. USA 90: 740–744.

  • Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC and Vogelstein B. . 1992 N. Engl. J. Med. 326: 737–740.

  • Siracusa LD, Rosner MH, Vigano MA, Gibert DJ, Staudt LM, Copeland NG and Jenkins NA. . 1991 Genomics 10: 313–326.

  • Smith G, Gallahan D, Zweibel J, Freeman S, Bassin R and Callahan R. . 1991 J. Virol. 65: 6365–6370.

  • Smith G and Medina D. . 1988 J. Cell. Sci. 89: 173–183.

  • Smith G, Vonderhaar B, Graham D and Medina D. . 1984 Cancer Res. 44: 3426–3437.

  • Smith GH. . 1965 J. Natl. Cancer Inst. 36: 685–701.

  • Smith GH. . 1967 Cancer Res. 27: 2170–2196.

  • Smith GH. . 1996 Breast Cancer Res. Treat. 39: 21–31.

  • Smith GH, Gallahan D, Diella F, Jhappan C, Merlino G and Callahan R. . 1995 Cell Growth Diff. 6: 563–577.

  • Smith GH and Vlahakis G. . 1982 Int. J. Cancer 29: 587–590.

  • Smolich BD, McMahon JA, McMahon AP and Papkoff J. . 1993 Mol. Biol. Cell. 4: 1267–1275.

  • Squartini F. . 1961 J. Natl. Cancer Inst. 26: 813–826.

  • Squartini F. . 1979 Pathology of tumours in laboratory animals. Vol II: Tumours of the mouse. Tumours in the mammary gland. IARC Scientific Publications No. 23 (WHO), London 43–90.

    Google Scholar 

  • Squartini F, Basolo F and Bistocchi M. . 1983 Cancer Res. 43: 5879–5882.

  • Squartini F, Rossi G and Paoletti G. . 1963 Nature (London) 197: 505–506.

  • Stamp G, Fantl V, Poulsm R, Jamieson S, Smith R, Peters G and Dickson C. . 1992 Cell Growth Diff. 3: 929–938.

  • Struhl G, Fitzgerald K and Greenwald I. . 1993 Cell 74: 331–345.

  • Teramoto YA, Horan Hand P, Callahan R and Schlom J. . 1980 J. Natl. Cancer Inst. 64: 967–975.

  • Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA and Smith HS. . 1996 Cancer Res. 56: 402–404.

  • Tsubura Y, Imai S, Morimoto J and Hilgers J. . 1981 Gann 72: 424–429.

  • Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T and Varmus HE. . 1988 Cell 55: 619–625.

  • Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D and Kitajewski J. . 1996 Development 122: 2251–2259.

  • Uyttendaele H, Soriano JV, Montesano R and Kitajewski J. . 1998 Dev. Biol. 196: 204–217.

  • Vande Vijver MJ, Petersen J, Mooi W, Lomans J, Verbruggen M, Vande Bersselaar A, Devilee P, Cornelisse C, Bos JL, Yarnold J and Nusse R. (eds). . 1989 Molecular Diagnostics of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.

    Google Scholar 

  • van Nie R and Verstraeten AA. . 1975 Int. J. Cancer 16: 922–931.

  • van Nie R, Verstraeten AA and De Moes J. . 1977 Int. J. Cancer 19: 383–390.

  • Varmus HE. . 1982 Cancer Surv. 1: 309–320.

  • Vlahakis G, Heston WE and Smith GH. . 1970 Science 170: 185–187.

  • Wainscoat JS and Fey MF. . 1990 Cancer Res. 50: 1355–1360.

  • Wang Y, Holland JF, Melana SM and Pogo BG. . 1998 Clin. Cancer Res. 4: 2565–2568.

  • Weinmaster G. . 1997 Mol. Cell. Neurosci. 9: 91–102.

  • Wellings SR. . 1980 Path. Res. Pract. 166: 515–535.

  • Wesley CS. . 1999 Mol. Cell. Biol. 19: 5743–5758.

  • Wilkinson DG, Peters G, Dickson G and McMahon AP. . 1988 EMBO J. 7: 691–695.

  • Withers-Ward ES, Kitamura Y, Barnes JP and Coffin JM. . 1994 Genes Dev. 8: 1473–1487.

  • Yoshida T, Miyagawa K, Odagiri H et al. 1987 Proc. Natl. Acad. Sci. USA 84: 7305–7309.

  • Young LJ, Medina D, DeOme KB and Daniel CW. . 1971 Exp. Gerontol. 6: 49–56.

Download references

Author information

Authors and Affiliations

  1. Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, 20892, Maryland, MD, USA

    Robert Callahan & Gilbert H Smith

Authors
  1. Robert Callahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gilbert H Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callahan, R., Smith, G. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 19, 992–1001 (2000). https://doi.org/10.1038/sj.onc.1203276

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203276

Keywords

This article is cited by

Search

Advanced search

Quick links